MaldanerN, DesaiA, GautschiOP, et al.Improving the patient-physician relationship in the digital era—Transformation from subjective questionnaires into objective real-time and patient-specific data reporting tools. Neurospine, 2019; 16(4):712–714.
2.
SosnovaM, ZeitlbergerAM, ZigaM, et al.Patients undergoing surgery for lumbar degenerative spinal disorders favor smartphone-based objective self-assessment over paper-based patient-reported outcome measures. Spine J, 2021; 21(4):610–617.
3.
ChurrucaK, PomareC, EllisLA, et al.Patient-reported outcome measures (PROMs): A review of generic and condition-specific measures and a discussion of trends and issues. Health Expect, 2021; 24(4):1015–1024.
4.
US Food and Drug Administration. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims; December 2009. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims [Last accessed: February 20, 2024].
5.
TurkDC, DworkinRH, AllenRR, et al.Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain, 2003; 106(3):337–345.
6.
DworkinRH, TurkDC, FarrarJT, et al.Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain, 2005; 113(1–2):9–19.
7.
OMERACT. Outcome Measures in Rheumatology. Available from: https://omeract.org/ [Last accessed: February 20, 2024].
8.
MeaseP, ArnoldLM, ChoyEH, et al.Fibromyalgia syndrome module at OMERACT 9: Domain construct. J Rheumatol, 2009; 36(10):2318–2329
9.
MeasePJ, ClauwDJ, ChristensenR, et al.Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update. J Rheumatol, 2011; 38(7):1487–1495.
10.
BaschE, DealAM, KrisMG, et al.Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. J Clin Oncol, 2016; 34(6):557–565.
